Back to
UBS Group AG
ICCC30 quarters
Position history for
UBS Group AG's holdings in IMMUCELL CORP
Yes. Ubs holds 1,000 shares of ICCC (Immucell), worth $10,050, as of its Q2 2026 13F filing. It reduced the position by 113 shares (-10.2%) from Q1 2026. Ubs has held ICCC in every 13F on record since Q1 2019, 30 quarterly filings.
Current Value
$10,050
Current Shares
1,000
Total Value Change
-$14,950
Total Shares Change
-3,000
Quarter-by-Quarter History
Other major holders of ICCC: WELLINGTON MANAGEMENT GROUP LLP, VANGUARD CAPITAL MANAGEMENT LLC, MORGAN STANLEY, VANGUARD GROUP INC